VituVingiSana wrote:sparkly wrote:VituVingiSana wrote:Ericsson wrote:The conversion price for the ARM shares was 40.
And vvs you were a fan of ARM.
Nope, not a fan (for a few years) but I have watched it with interest. I have no ARM shares though I do regret not buying them at 3/- in the late 90s. I have a few (insignificant) Bamburi bought back in the day.
Your chance to buy at 3 bob. Get a loan
So much choice, so little cash!
When do they usually release 1H results?
I remain cautious BUT as @xxxxx said, this could be a multi-bagger if they can get their cashflow problems behind them.
I think @Ericsson said the main lenders are Stanbic and AFC. Any insights on what the two want to do? [Killing off ARM might not be on the agenda but selling off the loss-making TZ biz - like KK did - could provide a lifeline.]
What's CDC's gameplan given it has 40%+ of ARM?
Will PHP be sacked?
I do hope ARM can be turned around since manufacturing is a value-adding industry from adding value to the local/EAC limestone deposits, EAC coal deposits to building in Kenya for Kenyans.
I do not believe PHP will be sacked. In fact, he sounds kind of happy and confident that the tough times are behind us now.
CDC recommended a $50M equity injection, plus a $90M term loan with a 3 year moratorium, plus further working capital lines of around $30M. The proposed tenor for the debt portion of the restructuring was proposed as a maximum of 10 years.
AFC, Stanbic, Aureos and other creditors will be paid off this time Fully using the funding from CDC and their short term debt replaced by CDCs working capital lines as well as part of the term loan facility. So they won't be having a say in the way forward. Recall that the AFC facility was one of the auditors biggest headaches. Its matures fully this year yet at audit time, ARM didn't provide any evidence regarding the source of refinancing to plug its hole.
With regards to the equity injection, finer details haven't yet been confirmed to us so all and sundry can draw their preliminary conclusions between now and when the detailed announcement is made. An additional dilution of $50M to steady the ship is very welcome for me as a current shareholder since it precludes cash calls from me in the very short run. It can do wonders ( Ask the TOTAL guys if in doubt)
Knowing what I know now, I wish I had acquired more of this thing. It's still a strong buy even at current prices if you have the dimez especially because CDC is in for the long haul ( or at least until turn around is completed) and this resolves the Going Concern question which freaked out Deloitte (the External Auditors) at the time of the final audit.
The negatives have been extremely magnified and priced in beyond what was reasonable, understandably so. However, as these fears get dispelled by credible information, I expect a decent price recovery (back to a minimum price of 10 or 15 in the near term.
We must move away from this piecemeal valuation of @ARMCEMENT as if it is not a going concern.
In view of the above, I'd be very disappointed if the Tanzanian plant is disposed of under any circumstances. I think it constitutes a core operational segment of ARM and all information indicates that it will survive.